Advertisement Moberg Pharma introduces Kerasal Complete Care in US - Pharmaceutical Business review
Pharmaceutical Business review is using cookies

ContinueLearn More
Close

Moberg Pharma introduces Kerasal Complete Care in US

Swedish pharmaceutical firm Moberg Pharma has launched its new line extension, Kerasal Complete Care, a new foot care product, in the US.

Kerasal Complete Care brings together two highly effective treatments to restore healthy nail appearance and treat toe and foot skin fungus (athlete’s foot) in a convenient dual-pack.

Moberg Pharma CEO Peter Wolpert said: "Until now, there has been no product on the market that addresses both these needs, marketed and promoted as a single convenient solution.

Kerasal Complete Care is a dual-pack kit that provides a daily single regimen for addressing both needs."

The product is targeted for consumers who have both damaged nails and toe and foot skin fungus.

It includes Kerasal Nail Fungal Renewal, clinically proven to improve nail appearance in as little as two weeks and; Kerasal Toe & Foot Anti-Fungal, a highly effective treatment based on clotrimazole 1%, for foot fungus.

The company announced that it has already delivered the new foot care product to Walgreens, the largest drug retailing chain in the US.

Starting in March 2015, Kerasal Complete Care will be sold in about 7,000 Walgreens locations in the foot care section.

Moberg’s portfolio includes the OTC brands Kerasal, Jointflex, Kerasal Nail, Domeboro, Vanquish, and Fergon as well as Phase II pipeline assets.